FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2106683936> ?p ?o ?g. }

• W2106683936 endingPage "708" @default.
• W2106683936 startingPage "698" @default.
• W2106683936 abstract "Examination of three retinoid X receptor (RXR) agonists [Targretin (TRG), UAB30, and 4-methyl-UAB30 (4-Me-UAB30)] showed that all inhibited mammary cancer in rodents and two (TRG and 4-Me-UAB30) strikingly increased serum triglyceride levels. Agents were administered in diets to female Sprague-Dawley rats. Liver RNA was isolated and microarrayed on the Affymetrix GeneChip Rat Exon 1.0 ST array. Statistical tests identified genes that exhibited differential expression and fell into groups, or modules, with differential expression among agonists. Genes in specific modules were changed by one, two, or all three agonists. An interactome analysis assessed the effects on genes that heterodimerize with known nuclear receptors. For proliferator-activated receptor α/RXR-activated genes, the strongest response was TRG > 4-Me-UAB30 > UAB30. Many liver X receptor/RXR-related genes (e.g., Scd-1 and Srebf1, which are associated with increased triglycerides) were highly expressed in TRG and 4-Me-UAB30- but not UAB30-treated livers. Minimal expression changes were associated with retinoic acid receptor or vitamin D receptor heterodimers by any of the agonists. UAB30 unexpectedly and uniquely activated genes associated with the aryl hydrocarbon hydroxylase (Ah) receptor (Cyp1a1, Cyp1a2, Cyp1b1, and Nqo1). Based on the Ah receptor activation, UAB30 was tested for its ability to prevent dimethylbenzanthracene (DMBA)-induced mammary cancers, presumably by inhibiting DMBA activation, and was highly effective. Gene expression changes were determined by reverse transcriptase-polymerase chain reaction in rat livers treated with Targretin for 2.3, 7, and 21 days. These showed similar gene expression changes at all three time points, arguing some steady-state effect. Different patterns of gene expression among the agonists provided insight into molecular differences and allowed one to predict certain physiologic consequences of agonist treatment." @default.
• W2106683936 created "2016-06-24" @default.
• W2106683936 creator A5002361220 @default.
• W2106683936 creator A5010174341 @default.
• W2106683936 creator A5013903102 @default.
• W2106683936 creator A5014024059 @default.
• W2106683936 creator A5017851498 @default.
• W2106683936 creator A5039459687 @default.
• W2106683936 creator A5060284538 @default.
• W2106683936 creator A5061594020 @default.
• W2106683936 creator A5081713465 @default.
• W2106683936 creator A5084834018 @default.
• W2106683936 date "2013-01-04" @default.
• W2106683936 modified "2023-10-17" @default.
• W2106683936 title "Effects on Gene Expression in Rat Liver after Administration of RXR Agonists: UAB30, 4-Methyl-UAB30, and Targretin (Bexarotene)" @default.
• W2106683936 cites W1514230952 @default.
• W2106683936 cites W1966327575 @default.
• W2106683936 cites W1967680216 @default.
• W2106683936 cites W1969525589 @default.
• W2106683936 cites W1983525976 @default.
• W2106683936 cites W1999669689 @default.
• W2106683936 cites W2000756557 @default.
• W2106683936 cites W2011303009 @default.
• W2106683936 cites W2015721847 @default.
• W2106683936 cites W2032388264 @default.
• W2106683936 cites W2042476798 @default.
• W2106683936 cites W2053186448 @default.
• W2106683936 cites W2060705109 @default.
• W2106683936 cites W2062438193 @default.
• W2106683936 cites W2076617497 @default.
• W2106683936 cites W2079977198 @default.
• W2106683936 cites W2081724586 @default.
• W2106683936 cites W2094498592 @default.
• W2106683936 cites W2109221130 @default.
• W2106683936 cites W2110891968 @default.
• W2106683936 cites W2118274595 @default.
• W2106683936 cites W2120150211 @default.
• W2106683936 cites W2120756864 @default.
• W2106683936 cites W2120865735 @default.
• W2106683936 cites W2122683221 @default.
• W2106683936 cites W2140276705 @default.
• W2106683936 cites W2146163489 @default.
• W2106683936 cites W2146644601 @default.
• W2106683936 cites W2159686118 @default.
• W2106683936 cites W2167988561 @default.
• W2106683936 doi "https://doi.org/10.1124/mol.112.082404" @default.
• W2106683936 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3583492" @default.
• W2106683936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23292798" @default.
• W2106683936 hasPublicationYear "2013" @default.
• W2106683936 type Work @default.
• W2106683936 sameAs 2106683936 @default.
• W2106683936 citedByCount "27" @default.
• W2106683936 countsByYear W21066839362014 @default.
• W2106683936 countsByYear W21066839362015 @default.
• W2106683936 countsByYear W21066839362016 @default.
• W2106683936 countsByYear W21066839362017 @default.
• W2106683936 countsByYear W21066839362018 @default.
• W2106683936 countsByYear W21066839362019 @default.
• W2106683936 countsByYear W21066839362020 @default.
• W2106683936 countsByYear W21066839362021 @default.
• W2106683936 countsByYear W21066839362022 @default.
• W2106683936 countsByYear W21066839362023 @default.
• W2106683936 crossrefType "journal-article" @default.
• W2106683936 hasAuthorship W2106683936A5002361220 @default.
• W2106683936 hasAuthorship W2106683936A5010174341 @default.
• W2106683936 hasAuthorship W2106683936A5013903102 @default.
• W2106683936 hasAuthorship W2106683936A5014024059 @default.
• W2106683936 hasAuthorship W2106683936A5017851498 @default.
• W2106683936 hasAuthorship W2106683936A5039459687 @default.
• W2106683936 hasAuthorship W2106683936A5060284538 @default.
• W2106683936 hasAuthorship W2106683936A5061594020 @default.
• W2106683936 hasAuthorship W2106683936A5081713465 @default.
• W2106683936 hasAuthorship W2106683936A5084834018 @default.
• W2106683936 hasBestOaLocation W21066839362 @default.
• W2106683936 hasConcept C104317684 @default.
• W2106683936 hasConcept C120197328 @default.
• W2106683936 hasConcept C126322002 @default.
• W2106683936 hasConcept C128821507 @default.
• W2106683936 hasConcept C134018914 @default.
• W2106683936 hasConcept C150194340 @default.
• W2106683936 hasConcept C153911025 @default.
• W2106683936 hasConcept C155701950 @default.
• W2106683936 hasConcept C170493617 @default.
• W2106683936 hasConcept C2778820923 @default.
• W2106683936 hasConcept C2778938436 @default.
• W2106683936 hasConcept C2778938600 @default.
• W2106683936 hasConcept C526171541 @default.
• W2106683936 hasConcept C55493867 @default.
• W2106683936 hasConcept C555283112 @default.
• W2106683936 hasConcept C62231903 @default.
• W2106683936 hasConcept C63932345 @default.
• W2106683936 hasConcept C68484354 @default.
• W2106683936 hasConcept C71924100 @default.
• W2106683936 hasConcept C76591681 @default.
• W2106683936 hasConcept C86339819 @default.
• W2106683936 hasConcept C86745063 @default.
• W2106683936 hasConcept C86803240 @default.
• W2106683936 hasConceptScore W2106683936C104317684 @default.

• next